SHOTS -NPR's Health Blog
CDC - Centers for Disease Control and Prevention
-----------------------------
NY Organ Donor Network
Making Health Care Safer
Smoking causes immediate damage
Get Smart for Healthcare
Centers for Disease Control and Prevention (CDC)

eHealth Topics

Donate Life America

Bertalan Mesko,MD,PhD
Editor-in-Chief

CDC.gov
CDC.gov

Alzheimer's Disease Education & Referral Center

Colorectal Cancer Screen
Adult Smoking
CDC.gov
Child Safety Network

Healthy Environment,Healthy Kids

NRC Widget

Impact of Home Versus Clinic-Based Management of Chronic Heart Failure The WHICH? (Which Heart Failure Intervention Is Most Cost-Effective &Consumer Friendly in Reducing Hospital Care) Multicenter,Randomized Trial

Objectives

The goal of this study was to make a head-to-head comparison of 2 common forms of multidisciplinary chronic heart failure (CHF) management.

Background

Although direct patient contact appears to be best in delivering CHF management overall,the precise form to optimize health outcomes is less clear.

Methods

This prospective,multicenter randomized controlled trial with blinded endpoint adjudication comprised 280 hospitalized CHF patients (73% male,age 71 ± 14 years,and 73% with left ventricular ejection fraction ≤45%) randomized to home-based intervention (HBI) or specialized CHF clinic–based intervention (CBI). The primary endpoint was all-cause,unplanned hospitalization or death during 12- to 18-month follow-up. Secondary endpoints included type/duration of hospitalization and healthcare costs.

Results

The primary endpoint occurred in 102 of 143 (71%) HBI versus 104 of 137 (76%) CBI patients (adjusted hazard ratio [HR]:0.97 [95% confidence interval (CI):0.73 to 1.30],p = 0.861):96 (67.1%) HBI versus 95 (69.3%) CBI patients had an unplanned hospitalization (p = 0.887),and 31 (21.7%) versus 38 (27.7%) died (p = 0.252). The median duration of each unplanned hospitalization was significantly less in the HBI group (4.0 [interquartile range (IQR):2.0 to 7.0] days vs. 6.0 [IQR:3.5 to 13] days;p = 0.004). Overall,75% of all hospitalization was attributable to 64 (22.9%) patients,of whom 43 (67%) were CBI patients (adjusted odds ratio:2.55 [95% CI:1.37 to 4.73],p = 0.003). HBI was associated with significantly fewer days of all-cause hospitalization (−35%;p = 0.003) and from cardiovascular causes (−37%;p = 0.025) but not for CHF (−24%;p = 0.218). Consequently,healthcare costs ($ AU3.93 vs. $ AU5.53 million) were significantly less for the HBI group (median:$ AU34 [IQR:13 to 81] per day vs. $ AU52 [17 to 140] per day;p = 0.030).

Conclusions

HBI was not superior to CBI in reducing all-cause death or hospitalization. However,HBI was associated with significantly lower healthcare costs,attributable to fewer days of hospitalization. (Which Heart failure Intervention is most Cost-effective &consumer friendly in reducing Hospital care [WHICH?];ACTRN12607000069459)
Journal of the American College of Cardiology Current Issue

Be Sociable,Share!

Leave a Reply

  

  

  

You can use these HTML tags

<a href=""title=""><abbr title=""><acronym title=""><b><blockquote cite=""><cite><code><del datetime=""><em><i><q cite=""><strike><strong>